Astatine-211 based radionuclide therapy: Current clinical trial landscape.
Albertsson P, Bäck T, Bergmark K, Hallqvist A, Johansson M, Aneheim E, Lindegren S, Timperanza C, Smerud K, Palm S.
Albertsson P, et al.
Front Med (Lausanne). 2023 Jan 6;9:1076210. doi: 10.3389/fmed.2022.1076210. eCollection 2022.
Front Med (Lausanne). 2023.
PMID: 36687417
Free PMC article.
Review.